
A new Northwestern Medicine study has found that metformin, a commonly prescribed diabetes drug, focuses primarily on the gut, acting to prevent glucose levels rising in the blood by driving glucose utilization inside cells lining the intestine.

A new Northwestern study suggests that interventions for epilepsy can start during pregnancy, as early as 15 weeks gestation, well before symptoms appear, according to a study published in Nature Communications.

The Northwestern University Clinical and Translational Sciences Institute has announced Keith Summa, MD, PhD, Timothy Janetos, MD, and Vidhi Dalal, MD, as its newest K12 scholars.

Robert Murphy, MD, executive director of the Robert J. Havey, MD Institute for Global Health, has been honored with the 2026 Consortium of Universities for Global Health (CUGH) Distinguished Leadership in Global Health Award.

New estimates of rates of sepsis during pediatric hospitalizations have been obtained by a multicenter team of investigators, using clinical data from electronic health records.

Northwestern scientists have developed flexible, low-cost devices that generate electrical signals realistic enough to activate living brain cells.

A new Northwestern Medicine study published in JAMA has found that a little-used cholesterol test outperformed standard tests in guiding cholesterol-lowering therapy.

Patients who received an experimental drug developed at Northwestern University alongside standard chemotherapy were twice as likely to be alive after one year of treatment, compared to those receiving chemotherapy alone.

A new Northwestern University study suggests that higher‑level brain systems that interpret and organize perception may play a central role in imagination in addition to sensory systems.

A new Northwestern study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug candidate to treat the cognitive symptoms of the disorder.